Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells

S. H. Lee, G. N. Shen, Y. S. Jung, S. J. Lee, J. Y. Chung, H. S. Kim, Y. Xu, Yongseok Choi, J. W. Lee, N. C. Ha, G. Y. Song, B. J. Park

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers. Recently, we have revealed that p53 is suppressed and eliminated from cells by direct binding with oncogenic K-Ras-induced Snail. On the basis of the fact, we generated specific inhibitors against p53-Snail binding (GN25 and GN29). These chemicals can induce p53 expression and functions in K-Ras-mutated cells. However, it does not show cytotoxic effect on normal cells or K-Ras-wild-type cells. Moreover, GN25 can selectively activate wild-type p53 in p53 WT/MT cancer cells. But single allelic mt p53 containing cell line, Panc-1, does not respond to our chemical. In vivo xenograft test also supports the antitumor effect of GN25 in K-Ras-mutated cell lines. These results suggest that our compounds are strong candidate for anticancer drug against K-Ras-initiated human cancers including pancreatic and lung cancers.

Original languageEnglish
Pages (from-to)4576-4587
Number of pages12
JournalOncogene
Volume29
Issue number32
DOIs
Publication statusPublished - 2010 Aug 12

Fingerprint

Neoplasms
Cell Line
Snails
Pancreatic Neoplasms
Heterografts
Lung Neoplasms
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Lee, S. H., Shen, G. N., Jung, Y. S., Lee, S. J., Chung, J. Y., Kim, H. S., ... Park, B. J. (2010). Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells. Oncogene, 29(32), 4576-4587. https://doi.org/10.1038/onc.2010.208

Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells. / Lee, S. H.; Shen, G. N.; Jung, Y. S.; Lee, S. J.; Chung, J. Y.; Kim, H. S.; Xu, Y.; Choi, Yongseok; Lee, J. W.; Ha, N. C.; Song, G. Y.; Park, B. J.

In: Oncogene, Vol. 29, No. 32, 12.08.2010, p. 4576-4587.

Research output: Contribution to journalArticle

Lee, SH, Shen, GN, Jung, YS, Lee, SJ, Chung, JY, Kim, HS, Xu, Y, Choi, Y, Lee, JW, Ha, NC, Song, GY & Park, BJ 2010, 'Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells', Oncogene, vol. 29, no. 32, pp. 4576-4587. https://doi.org/10.1038/onc.2010.208
Lee, S. H. ; Shen, G. N. ; Jung, Y. S. ; Lee, S. J. ; Chung, J. Y. ; Kim, H. S. ; Xu, Y. ; Choi, Yongseok ; Lee, J. W. ; Ha, N. C. ; Song, G. Y. ; Park, B. J. / Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells. In: Oncogene. 2010 ; Vol. 29, No. 32. pp. 4576-4587.
@article{0f251f8f748146dabec20a4e024ed167,
title = "Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells",
abstract = "p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers. Recently, we have revealed that p53 is suppressed and eliminated from cells by direct binding with oncogenic K-Ras-induced Snail. On the basis of the fact, we generated specific inhibitors against p53-Snail binding (GN25 and GN29). These chemicals can induce p53 expression and functions in K-Ras-mutated cells. However, it does not show cytotoxic effect on normal cells or K-Ras-wild-type cells. Moreover, GN25 can selectively activate wild-type p53 in p53 WT/MT cancer cells. But single allelic mt p53 containing cell line, Panc-1, does not respond to our chemical. In vivo xenograft test also supports the antitumor effect of GN25 in K-Ras-mutated cell lines. These results suggest that our compounds are strong candidate for anticancer drug against K-Ras-initiated human cancers including pancreatic and lung cancers.",
keywords = "anticancer drug, K-Ras, p53, pancreatic cancer, Snail",
author = "Lee, {S. H.} and Shen, {G. N.} and Jung, {Y. S.} and Lee, {S. J.} and Chung, {J. Y.} and Kim, {H. S.} and Y. Xu and Yongseok Choi and Lee, {J. W.} and Ha, {N. C.} and Song, {G. Y.} and Park, {B. J.}",
year = "2010",
month = "8",
day = "12",
doi = "10.1038/onc.2010.208",
language = "English",
volume = "29",
pages = "4576--4587",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "32",

}

TY - JOUR

T1 - Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells

AU - Lee, S. H.

AU - Shen, G. N.

AU - Jung, Y. S.

AU - Lee, S. J.

AU - Chung, J. Y.

AU - Kim, H. S.

AU - Xu, Y.

AU - Choi, Yongseok

AU - Lee, J. W.

AU - Ha, N. C.

AU - Song, G. Y.

AU - Park, B. J.

PY - 2010/8/12

Y1 - 2010/8/12

N2 - p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers. Recently, we have revealed that p53 is suppressed and eliminated from cells by direct binding with oncogenic K-Ras-induced Snail. On the basis of the fact, we generated specific inhibitors against p53-Snail binding (GN25 and GN29). These chemicals can induce p53 expression and functions in K-Ras-mutated cells. However, it does not show cytotoxic effect on normal cells or K-Ras-wild-type cells. Moreover, GN25 can selectively activate wild-type p53 in p53 WT/MT cancer cells. But single allelic mt p53 containing cell line, Panc-1, does not respond to our chemical. In vivo xenograft test also supports the antitumor effect of GN25 in K-Ras-mutated cell lines. These results suggest that our compounds are strong candidate for anticancer drug against K-Ras-initiated human cancers including pancreatic and lung cancers.

AB - p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers. Recently, we have revealed that p53 is suppressed and eliminated from cells by direct binding with oncogenic K-Ras-induced Snail. On the basis of the fact, we generated specific inhibitors against p53-Snail binding (GN25 and GN29). These chemicals can induce p53 expression and functions in K-Ras-mutated cells. However, it does not show cytotoxic effect on normal cells or K-Ras-wild-type cells. Moreover, GN25 can selectively activate wild-type p53 in p53 WT/MT cancer cells. But single allelic mt p53 containing cell line, Panc-1, does not respond to our chemical. In vivo xenograft test also supports the antitumor effect of GN25 in K-Ras-mutated cell lines. These results suggest that our compounds are strong candidate for anticancer drug against K-Ras-initiated human cancers including pancreatic and lung cancers.

KW - anticancer drug

KW - K-Ras

KW - p53

KW - pancreatic cancer

KW - Snail

UR - http://www.scopus.com/inward/record.url?scp=77955659716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955659716&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.208

DO - 10.1038/onc.2010.208

M3 - Article

VL - 29

SP - 4576

EP - 4587

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 32

ER -